0      0

2020 GAPNA Annual Conference


ISPT01 - A Deeper Dive into the Use of Myrbetriq® (mirabegron) in Patients 65 and Older with OAB Symptoms of Urge Urinary Incontinence, Urgency, and Urinary Frequency


Sep 23, 2020 4:00pm ‐ Sep 23, 2020 5:00pm

Description

A Deeper Dive into the Use of Myrbetriq® (mirabegron) in Patients 65 and Older with OAB Symptoms of Urge Urinary Incontinence, Urgency, and Urinary Frequency Supported by: Astellas Pharma US, Inc.

Supported by Astellas Pharma US, Inc. This session discusses the clinical impact and physiology of overactive bladder, as well as the latest perspectives on management and treatment.

Request a Rep

Speaker(s):

You must be logged in and own this session in order to post comments.

Print Certificate
Completed on: token-completed_on
Print Transcript
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
rendered in: 
* - Indicates answer is required.
token-content

token-speaker-name
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content
token-index
token-content